Similar to 6,7-Dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline , Psychopharmacology, Pharmaceuticals
Nitoman · Orphan Brand of Tetrabenazine · Tetrabenazine Orphan Brand
Tetrabenazine is a drug for the symptomatic treatment of hyperkinetic movement disorders. It is marketed under the trade names Nitoman in Canada and Xenazine in New Zealand, some parts of Europe and in the United States as an orphan drug. On August 15, 2008, the U.S.